Angela Dispenzieri, expert in amyloidosis treatment and diagnosis, discusses the importance of early diagnosis and raising awareness of AL amyloidosis. She highlights the superior results shown by the combination regimen of dara tumumab, cyclophosphamide, bortezimib, and dexamethasone in clinical trials. The podcast explores unmet needs in the field, emphasizes the importance of supportive care and expertise in amyloid centers, and discusses ongoing clinical trials and the potential of immunotherapy and Veneta Clax in treating AL amyloidosis.
